MoneyWorks4Me

Kimia Biosciences - Quaterly Results

13 Feb 2025 Evaluate
The Revenue for the quarter ended  December 2024 of Rs. 300.99 millions grew by 15.12 % from Rs. 261.45 millions.The Total Profit for the quarter ended December 2024 of Rs. 45.70 millions grew from Rs.-19.52 millions Operating profit Margin for the quarter ended December 2024 improved to 54.20% as compared to -4.71% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 300.99 261.45 15.12 806.77 745.75 8.18 1048.77 1285.16 -18.39
Other Income 4.24 5.76 -26.39 8.78 13.38 -34.38 16.42 12.13 35.37
PBIDT 54.20 -4.71 -1250.74 129.50 -33.09 -491.36 11.59 -37.63 -130.80
Interest 10.08 13.11 -23.11 31.55 37.06 -14.87 50.50 42.45 18.96
PBDT 44.12 -17.82 -347.59 97.95 -70.15 -239.63 -38.91 -90.56 -57.03
Depreciation 8.16 8.19 -0.37 25.00 24.74 1.05 32.92 33.32 -1.20
PBT 35.96 -26.01 -238.25 72.95 -94.89 -176.88 -71.83 -123.88 -42.02
TAX -9.74 -6.49 50.08 -3.28 -23.85 -86.25 -18.75 -30.36 -38.24
Deferred Tax -3.57 -6.49 -44.99 -3.28 -23.85 -86.25 -18.75 -30.36 -38.24
PAT 45.70 -19.52 -334.12 76.23 -71.04 -207.31 -53.08 -93.52 -43.24
Equity 47.31 47.31 0.00 47.31 47.31 0.00 47.31 47.31 0.00
PBIDTM(%) 18.01 -1.80 -1099.57 16.05 -4.44 -461.76 1.11 -2.93 -137.74
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..